Swedish drug development services provider Inhalation Sciences Sweden has been acquired by a consortium comprising Per Gerde, Fredrik Sjovall, and Rasunda Forvaltning.
Per Gerde is the founder of the target company, whereas Fredrik Sjovall is its CEO.
Go deeper with GlobalData
The stake was sold by KDev Investments, an investment firm held jointly by Karolinska Development and Rosetta Capital.
With the aim of further expanding its presence in the US, Quotient Clinical has acquired US-based contract development and manufacturing services provider, QS Pharma.
Based in the UK, Quotient Clinical provides drug development services. The acquisition has been made from Charles River Laboratories International, a US-based pre-clinical and clinical laboratory services provider.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
